A lawsuit was filed on behalf of investors in MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) shares over alleged securities laws violations.
San Diego, CA -- (SBWIRE) -- 06/19/2018 -- An investor, who purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX), filed a lawsuit over alleged violations of Federal Securities Laws by MabVax Therapeutics Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) have certain options and for certain investors are short and strict deadlines running. Deadline: August 3, 2018. NASDAQ:MBVX investors should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The plaintiff claims that between March 14, 2016 and May 18, 2018, the defendants failed to disclose, that the Company's internal controls over financial reporting were materially weak and deficient, that the Company had incorrectly calculated and reported beneficial ownership of MabVax Therapeutics Holdings, Inc shares, and permitted improper influence or control over MabVax Therapeutics Holdings, Inc, and/or the Company's officers and directors by certain shareholders, and that that, as a result of the foregoing, the Company's financial statements and Defendants' statements about MabVax Therapeutics Holdings, Inc's business, operations, and prospects, were materially false and misleading at all relevant times.
Those who purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels